Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

18.40
Delayed Data
As of Apr 28
 -1.40 / -7.07%
Today’s Change
7.05
Today|||52-Week Range
24.00
+23.49%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close19.80
Today’s open18.85
Day’s range17.50 - 19.04
Volume618,698
Average volume (3 months)238,157
Market cap$647.0M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)+13.11%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...-0.53-2.53%
RVNCRevance Therapeutics...-1.55-6.65%
KERXKeryx Biopharmaceuti...+0.02+0.34%
ARDXArdelyx Inc-0.50-3.60%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts